SUBSCRIBE
SUBSCRIBE

Homology Medicines

NEWS
Homology Medicines merged with Q32 Bio in 2024.
Business
More Women Named to Life Science Boards of Directors but Gender Gap Continues
Despite raised awareness over the past few years, the gender diversity gap in the boardrooms of Fortune 1000 companies has remained at slightly less than 20 percent, as of 2017. There is evidence though that shows companies with more diversity at the highest levels see a higher return on investment overall.
May 2, 2018
 · 
3 min read
 · 
Alex Keown
IPO letter in the billboard screen
Business
Homology Medicines Snags $144 Million IPO
Homology Medicines has raised $144 million in an initial public offering of stock.
March 28, 2018
 · 
2 min read
 · 
Alex Keown
Roche Could Take a $500M Hit Over Patent Losses
Business
Booming Homology Inks Deal for Huge New Massachusetts HQ
Things are looking up for Massachusetts-based Homology Medicines.
January 18, 2018
 · 
2 min read
 · 
Alex Keown
Why This Biotech, Up 300% Since May, Could be the Next Big M&A Target
Drug Development
Massachusetts’ Homology Medicines Snags $83.5M to Advance AMEnDR into Human Trials
August 1, 2017
 · 
2 min read
Business
The Next Generation: Top 20 Life Science Startups to Watch in 2017
BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.
January 3, 2017
 · 
11 min read
 · 
Mark Terry
What You Need to Know About Homology Medicines
Business
What You Need to Know About Homology Medicines
January 3, 2017
 · 
2 min read
Load More
AWARDS
  • NextGen Class of 2017
JOBS
IN THE PRESS
Business
Homology Medicines Reports Second Quarter 2022 Financial Results, Recent Highlights and Provides Business Update
August 15, 2022
 · 
13 min read
Genetown
Homology Medicines Announces Optimized, In Vivo Gene Therapy Candidate for the Treatment of Metachromatic Leukodystrophy
August 11, 2022
 · 
7 min read
Genetown
Homology Medicines Announces Peer-Reviewed Publication on Novel Discovery of AAVHSC with Robust Distribution to the Central Nervous System and Peripheral Organs with Low Affinity for the Liver
July 5, 2022
 · 
8 min read
Genetown
Homology Medicines to Present at Upcoming Conferences on its Gene Editing and Gene Therapy Programs for PKU
June 29, 2022
 · 
2 min read
Policy
Homology Medicines Announces FDA Lifted Clinical Hold on pheNIX Gene Therapy Trial for PKU
June 13, 2022
 · 
6 min read
Genetown
Homology Medicines Presents Details of Optimized HMI-103 Nuclease-Free Gene Editing Candidate Featuring Integrated Liver-Specific Promoter to Maximize Long-Term Expression
May 18, 2022
 · 
9 min read
Business
Homology Medicines Reports First Quarter 2022 Financial Results and Recent Highlights
May 16, 2022
 · 
13 min read
Genetown
Homology Medicines Announces Upcoming Presentation on Optimized In Vivo Gene Editing Candidate HMI-103 with First Details of Unique Mechanism of Action at ASGCT Annual Meeting
May 2, 2022
 · 
7 min read
Business
Homology Medicines Announces Promotion of Albert Seymour, Ph.D., to President
April 21, 2022
 · 
7 min read
Business
Homology Medicines Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
March 23, 2022
 · 
14 min read
Load More